Spotlight on Dasatinib in Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia†

By McCormack Paul L.   Keam Susan J.  

BioDrugs, Vol. 26, Iss. 1, 2012-02 ,pp. : 61-64

Adis International

Access to resources Recommend Favorite

Activity and Safety of Dasatinib as Second-Line Treatment or in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients

By Breccia Massimo   Alimena Giuliana  

BioDrugs, Vol. 25, Iss. 3, 2011-06 ,pp. : 147-157

Adis International

Access to resources Recommend Favorite

A novel mutation of SETBP1 in atypical chronic myeloid leukemia transformed from acute myelomonocytic leukemia

By  

Clinical Case Reports, Vol. 3, Iss. 6, 2015-06 ,pp. : 448-452

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diagnosis of intrachromosomal amplification of chromosome 21 (iAMP21) by molecular cytogenetics in pediatric acute lymphoblastic leukemia

By  

Clinical Case Reports, Vol. 3, Iss. 10, 2015-10 ,pp. : 814-816

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chronic Bullous Disease of Childhood in a Patient with Acute Lymphoblastic Leukemia: Possible Induction by a Drug

By Polat Muhterem  

American Journal of Clinical Dermatology, Vol. 8, Iss. 6, 2007-01 ,pp. : 389-391

Adis International

Access to resources Recommend Favorite